Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.72 |
| ▸ | MTOR | P42345 | 2/20 | 0.72 |
| ▸ | THRB | P10828 | 1/20 | 0.72 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.72 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.72 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | TP53 | P04637 | 2/20 | 0.51 |
| ▸ | GMNN | O75496 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.51 |
| ▸ | THPO | P40225 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | HBB | P68871 | 1/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.51 |
| ▸ | SLC29A1 | Q99808 | 3/20 | 0.50 |
| ▸ | SLC28A1 | O00337 | 2/20 | 0.50 |
| ▸ | SLC28A2 | O43868 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6302404 | 1.00 | LMNA (0.72) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL42103 | 1.00 | LMNA (0.72) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL30664789 | 1.00 | LMNA (0.72) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL16941689 | 0.99 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL16946221 | 0.99 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| Water SCHEMBL6475036 | 0.99 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| Water SCHEMBL6475042 | 0.99 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL20953417 | 0.99 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL20953418 | 0.99 | LMNA (0.70) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL16576161 | 0.88 | LMNA (0.57) | LMNAMTORTHRBMDM2NCOA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3693 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4711452-A2 | KLOTHO MRNA | ADvantage Therapeutics, Inc. (US) | 2026-03-18 | — | — | EP | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4696703-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2026-02-18 | — | — | EP | claimed |
| US-20250345406-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | SHATTUCK LABS INC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250340868-A1 | POLYNUCLEOTIDES ENCODING LINKED ANTIGENS AND USES THEREOF | STEMCELL TECHNOLOGIES CANADA INC (CA) | 2025-11-06 | — | — | US | claimed |
| US-20250325494-A1 | COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID | THEMEDIUM THERAPEUTICS CO., LTD. (CN) | 2025-10-23 | — | — | US | claimed |
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4631970-A2 | NUCLEIC ACID MOLECULES AND USES THEREOF | CureVac SE (DE) | 2025-10-15 | — | — | EP | claimed |
| EP-3630985-B1 | SYNTHESIS AND STRUCTURE OF HIGH POTENCY RNA THERAPEUTICS | ARCTURUS THERAPEUTICS INC (US) | 2025-08-27 | — | — | EP | claimed |
| WO-2005079849-A2 | COMPOUNDS FOR ENHANCED CANCER THERAPY | ZGENE A/S (DK) | 2005-09-01 | — | — | WO | claimed |
| EP-1572902-A3 | HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES | AMBION, INC. (US) | 2005-08-25 | — | — | EP | claimed |
| US-20030166282-A1 | High potency siRNAS for reducing the expression of target genes | APPLIED BIOSYSTEMS, LLC | 2003-09-04 | — | — | US | claimed |
| WO-2003064621-A2 | HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES | AMBION, INC. (US) | 2003-08-07 | — | — | WO | claimed |
| WO-2001010882-A9 | DEPOT FORMS OF MODIFIED NUCLEOSIDE 5'-HYDROGENPHOSPHATES AS INHIBITORS OF REPRODUCTION OF HUMAN IMMUNODEFICIENCY VIRUS AND HUMAN HEPATITIS B VIRUS | ADANI ALEXANDER (CA) | 2002-08-29 | — | — | WO | claimed |
| WO-2001010882-A1 | DEPOT FORMS OF MODIFIED NUCLEOSIDE 5'-HYDROGENPHOSPHATES AS INHIBITORS OF REPRODUCTION OF HUMAN IMMUNODEFICIENCY VIRUS AND HUMAN HEPATITIS B VIRUS | ADANI, ALEXANDER (CA) | 2001-02-15 | — | — | WO | claimed |
| EP-0673783-B1 | Recording sheets containing purine, pyrimidine, benzimidazole, imidazolidine, urazole, pyrazole, triazole, benzotriazole, tetrazole, and pyrazine compounds | XEROX CORP (US) | 2000-07-05 | — | — | EP | claimed |
| CN-1231895-A | Use of 2',3'-dideoxy-3'-thiocytidine in medicine for treatment of hepatitis B | JIANG WEI (CN) | 1999-10-20 | — | — | CN | claimed |
| WO-1991004982-A1 | FURTHER ANTIVIRAL PYRIMIDINE NUCLEOSIDES | UNIVERSITY OF BIRMINGHAM (GB) | 1991-04-18 | — | — | WO | claimed |
| EP-0421777-A1 | Further antiviral pyrimidine nucleosides | THE UNIVERSITY OF BIRMINGHAM (GB) | 1991-04-10 | — | — | EP | claimed |